Article
Duchenne Muscular Dystrophy: recent advances in protein biomarkers and the clinical application
3 May 2020
Abstract excerpt
INTRODUCTION: Early biomarker discovery studies have praised the value of their emerging results, predicting an unprecedented impact on health care. Biomarkers are expected to provide tests with increased specificity and sensitivity compared to existing measures, improve the decision-making process, and accelerate the development of therapies. For rare disorders, like Duchenne Muscular Dystrophy (DMD) such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
